What level of physical activity is helpful?

Share on Pinterest
Who does exercise benefit the most when it comes to cardiovascular disease risk? A new study investigates. Image credit: Kristian Buus/In Pictures via Getty Images
  • Cardiovascular disease is an umbrella term for disorders that impact either the heart, blood vessels, or both.
  • Moderate-to-vigorous physical activity has many benefits, but it may provide the most help to people who already have cardiovascular disease.
  • Physical activity that individuals do during their leisure time may provide the highest level of health benefits.

Cardiovascular disease, or all disorders that impact the heart or blood vessels, is highly prevalent and serious. Experts estimate that almost half of all American adults have some form of cardiovascular disease.

A recent study that appears in PLOS Medicinefound that individuals with cardiovascular disease can reap high benefits from physical activity.

However, among healthy individuals, there comes the point where increasing the level of physical exercise does not provide additional health benefits.

But researchers in this study found that the benefits of physical activity did not reach a similar plateau among participants with cardiovascular disease.

Cardiovascular disease (CVD) is a broad term. As the National Institutes of Health (NIH) notes, CVD is any disease that impacts the heart or blood vessels, while heart disease includes disorders that specifically affect the heart.

Several disorders fall under the category of CVD, including:

The treatments for CVD can vary. Depending on the severity of the issue, people with CVD may need to take medications or undergo surgery.

Several risk factors increase a person’s risk of getting CVD. For example, the Centers for Disease Control and Prevention (CDC) note that having high blood pressure, high cholesterol, or diabetes increases a person’s risk for heart disease.

People can modify some risk factors to help prevent adverse health outcomes due to CVD.

Experts are still discovering how individuals can best prevent CVD and reduce their overall risk of death. Physical activity has been the subject of many studies, and experts are still learning who benefits from it the most.

The study in question was a cohort study that researchers conducted in the Netherlands. It included a total of 142,493 participants. The team wanted to find out if people’s cardiovascular health status impacted the overall benefit of physical activity.

In other words, is physical activity helpful for everyone at the same level or does it help those who already have CVD more?

Researchers also wanted to find out if the reason for the physical activity impacted the benefits. For example, are people who have to be physically active for a job reaping the same benefits as those who are physically active in their leisure time?

Because there are so many risk factors and CVD includes many disorders, researchers in this study had to define their terms carefully.

They looked at three broad groups of people and used the following definitions:

  • Healthy individuals: These participants had all cardiovascular risk factors in a normal range and reported no known CVD.
  • Individuals with at least one CVD risk factor: These participants had either self-reported high blood pressure, high cholesterol, and/or diabetes, plus medications to control the respective risk factors, or had confirmed high cholesterol or blood sugar levels, and no reported CVD.
  • Individuals with CVD: These individuals had a history of heart failure, heart attack, or stroke and used medications for these conditions.

Each participant filled in a baseline questionnaire and undertook a physical exam. The questionnaire included information about lifestyle, health history, and diet. Researchers collected baseline data from each participant and followed up with them an average of 6.8 years later after collecting the baseline data.

The team further questioned participants about their level of physical activity. This information determined each participant’s amount of exercise that fit the study’s definition of moderate to vigorous.

They also divided types of physical activity into three categories:

  1. Leisure physical activity was all the moderate-to-vigorous physical activity that participants did during their leisure time.
  2. Nonleisure physical activity was all the moderate-to-vigorous physical activity that people did not do in their leisure time, such as during work or household chores.
  3. Occupational physical activity was all the moderate-to-vigorous physical activity that participants did related to work. This was a subcategory of nonleisure physical activity.

The team looked at the relationship between moderate-to-vigorous physical activity, all causes of death, and major adverse cardiovascular events. They included heart attacks, strokes, chronic and acute heart failure, and any major heart or chest-related surgeries, such as heart transplants and heart bypass surgeries, in their analysis of major adverse cardiovascular events.

Researchers found that overall, moderate-to-vigorous physical activity had links to lower all-cause mortality and major adverse cardiovascular events. But they also found that it was most beneficial to the group of participants that already had CVD.

Study first author, Dr. Esmée Bakker, explained to Medical News Today that “for healthy individuals and those with cardiovascular risk factors, such as hypertension and diabetes, we found that increasing exercise volumes led to a gradual risk reduction up to a point at which a plateau occurs.”

Dr. Bakker went on to explain that this result was different for participants who already had CVD:

“Cardiovascular disease patients demonstrated a different pattern, however, with every increase in physical activity volume leading to a further risk reduction of mortality and cardiovascular events. This finding emphasizes that more exercise is better for [CVD] patients.”

Researchers also found that moderate-to-vigorous physical activity that participants did in their leisure time was associated with the highest level of health benefits. Nonleisure moderate-to-vigorous physical activity was associated with some health benefits, and occupational moderate-to-vigorous physical activity was associated with no benefits.

Overall, the researchers concluded that physical activity recommendations should consider cardiovascular health status and the physical activity’s — leisure versus nonleisure — nature.

However, the study did have some limitations. First of all, the research was observational, meaning it cannot prove that higher physical activity prevents mortality or adverse cardiovascular events. Secondly, some of the data were self-reported, which runs the risk of inaccurate data collection.

Dr. Edo Paz, cardiology specialist VP of Medical at K Health, noted the following study limitations to MNT:

“First off, activity level is self-reported, which can be inaccurate. Another key limitation of this study is that it is an observational study and thus limited by confounding. That means that exercise may be highly correlated with another factor (like weight, nutritional status, etc.), and it is actually that other factor that predicts cardiovascular events. Although the authors tried to account for these confounding factors, it is not possible to collect or control for them all.”

Finally, the authors did not examine the impact of light intensity physical activity — the study specifically examined moderate-to-vigorous physical activity.

The researchers note that other studies have looked at how doing some physical activity is better than doing none at all. They note that starting with lower levels of physical activity can help some people increase their regular physical activity level.

It is also important to remember that everyone is different, and physical activity levels will look different for different people.

Dr. Paz told MNT: “It seems clear that physical activity is an important part of a healthy lifestyle, which is why the American Heart Association (AHA) recommends getting 150 minutes per week of moderate-intensity aerobic activity or 75 minutes per week of vigorous aerobic activity. However, this study indicates that these recommendations should always be personalized.”

Overall, the results indicate that physical activity recommendations should take into account a person’s cardiovascular health.

Dr. Bakker explained that the “[o]utcomes from this study are useful to further optimize physical activity recommendations by taking cardiovascular health status into account so that every individual, irrespective of cardiovascular health status, can optimally benefit from a physically active lifestyle.”

Further research would include looking at how to implement the best exercise plans for people with CVD.

Cardiology specialist Prof. Bernard Cheung — Sun Chieh Yeh Heart Foundation professor in Cardiovascular Therapeutics at the University of Hong Kong Faculty of Medicine — explained to MNT that “[c]aution should be exercised before getting cardiovascular disease patients to exercise to their limits […] more research is needed on what exercise programs are best for patients with different forms of cardiovascular disease (e.g., angina, heart failure).”

“The present study highlights the importance of evidence-based recommendations in this area,” he noted.

Trump reportedly got positive COVID test days before debate with Biden

1 in 100 patients may have brain complications

Artwork showing internal brain anatomy.Share on Pinterest
In people with severe COVID-19, central nervous system complications may be more common than initially estimated. Mental Art + Design/Stocksy
  • A large international study suggests that around 1 in every 100 patients hospitalized with COVID-19 have brain complications.
  • These include stroke, brain hemorrhage, and other potentially fatal conditions.
  • Many of the patients had preexisting illnesses, such as high blood pressure, heart disease, and diabetes.
  • Previous research has shown that some people who recover from COVID-19 have lingering neurological and psychiatric symptoms.

As the COVID-19 pandemic wears on, experts increasingly recognize that SARS-CoV-2, the virus that causes the disease, affects areas beyond the lungs. It can also infect the kidneys, gut, and blood vessels, for example.

In addition, COVID-19 can cause a range of neurological and psychiatric symptoms.

One telltale symptom is a loss of taste or smell, which indicates that SARS-CoV-2 can infect the peripheral nervous system. But the virus can also affect the central nervous system, producing symptoms such as headaches, dizziness, confusion, and seizures.

Now, a large international study led by researchers at Thomas Jefferson University, in Philadelphia, has found that around 1{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of patients hospitalized with COVID-19 develop potentially fatal brain complications.

These include strokes, bleeding, and inflammation called encephalitis.

“Much has been written about the overall pulmonary [lung] problems related to COVID-19, but we do not often talk about the other organs that can be affected,” says Dr. Scott H. Faro, a professor of radiology and neurology at the university, who also led the study.

“Our study shows that central nervous system complications represent a significant cause of morbidity and mortality in this devastating pandemic,” he explains.

The researchers presented their currently unpublished results at the annual meeting of the Radiological Society of North America, in Chicago. The study has yet to be peer reviewed, and only a summary of the results is available.

The retrospective, observational study involved almost 40,000 patients, who were hospitalized with COVID-19 at any of seven university hospitals in the United States or four in Western Europe.

The participants’ average age was 66 years, and there were twice as many men as women.

Many had preexisting conditions, such as heart disease, diabetes, or high blood pressure, which is also called hypertension.

Among those who had undergone a brain MRI or CT scan, 442 patients had brain-related complications attributable to COVID-19.

This suggests that around 1.2{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of the total patient group had a brain complication as a result of the disease.

The most frequent complications were:

  • ischemic stroke: 6.2{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.
  • hemorrhage, or bleeding: 3.72{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.
  • encephalitis: 0.47{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809}.

More rare complications included inflammation of the brain and spinal cord, which is called acute disseminating encephalomyelitis, and encephalopathy syndrome, which causes symptoms similar to those of a stroke.

“It is important to know an accurate incidence of all the major central nervous system complications,” Dr. Faro says, noting, “There should probably be a low threshold to order brain imaging for patients with COVID-19.”

Overall, brain complications appeared to be about three times as common among patients in Europe, compared with those in the U.S.

The study could not explain the factors behind this disparity. However, doctors detected strokes more often in COVID-19 patients in the U.S. than in Europe.

“The one feature that is likely a contributing factor is: There was an increase in comorbidities (cardiac, diabetes, and chronic [kidney] failure) in the U.S. population [compared with] Europe,” Dr. Faro told Medical News Today.

Currently, the direct role that the viral infection of the central nervous system plays in the neurological complications is unclear.

Overactivation of the immune system, inflammation, dehydration, and low oxygen levels, an issue called hypoxia, are also likely to be important factors.

“The [central nervous system] complications of COVID-19 are multifactorial and [involve] both the direct spread of the virus from the lungs and nasal mucosa, as well as indirect autoimmune factors and physiological changes (hypoxia, inflammation, dehydration),” Dr. Faro told MNT.

“More research is needed to better [understand] this,” he added.

The acute effects of COVID-19 on the central nervous system may result in lingering neurological and cognitive symptoms.

A study published in October found that some people who recover from the infection experience cognitive impairments, such as problems with concentration and memory, often called brain fog, for several months.

There may also be long-term effects on mental health.

A study published in May found that in the 6 months after recovering from COVID-19, 13{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of participants received a first diagnosis of a neurological or psychiatric condition.

The most common diagnoses were anxiety disorders, mood disorders, substance misuse disorders, and insomnia.

Neurological diagnoses were less common, and included strokes, dementia, and brain hemorrhages.

It is unknown whether COVID-19 was directly responsible for these neurological and psychiatric conditions.

The senior author of this study, Paul Harrison, a professor of psychiatry at the University of Oxford, told MNT that he and colleagues are conducting a follow-up study to see whether the effects continue beyond the 6-month period.

“We are looking at longer-term outcomes now and hope to have [our] study completed early next year,” he said.

Nation and world news at a glance

Fantasy Football Today: Who’s in, who’s out for Week 12

Whether you got off to a great start in Thursday’s games or you’re looking to make up ground, you’re going to have a lot of questions about your lineups this week, I know. Adam Aizer and Heath Cummings updated you on the latest news and answered some start/sit questions on this morning’s FFT podcast, and Jamey Eisenberg, Dave Richard, and Heath are on CBS Sports HQ until kickoff of the 1 p.m. games to answer your questions and keep you updated on all of the news you need to know on the FFT live show. 

Make sure you check both out, but if you want more direct answers to your questions and other news updates, I have two more ways for you to win: Go to Twitter and use the hashtag “#AskFFT”, where our whole team will be answering questions all morning; and go to the FFT YouTube channel to chat with Adam and I from 11:30 until kickoff. We’ll be there right up until kickoff answering as many questions as we can, so make sure you’re in the chat early to get your questions in. 

Here’s the rest of our preview content to get you ready, and check out my updated position rankings at the bottom of the newsletter to help with any early lineup dilemmas you may have: 

Sep 12, 2021; Nashville, Tennessee, USA; Tennessee Titans wide receiver Julio Jones (2) and Tennessee Titans wide receiver A.J. Brown (11) before the game against the Arizona Cardinals at Nissan Stadium.
Sean M. Haffey/Getty Images

Quarterbacks

Zach Wilson will make his return to the starting lineup for the Jets after missing four games with a knee sprain, and he has a nice soft landing spot against the Texans. Nobody should be planning on using him for Fantasy, so the biggest question is really whether he’ll play well enough to keep Elijah Moore’s breakout rolling and to get Ty Johnson involved in the passing game. 

Running backs

McNichols is actually the biggest injury here, because it seemingly frees up Dontrell Hilliard to play a big role again. Hillard surprisingly emerged as the most-used running back for the Titans in Week 11, catching eight passes and finishing with 82 yards from scrimmage. The Titans have a tough matchup against the Patriots on the way this week, but given the Titans’ injuries at both running back and wide receiver, it’s going to be hard to go away from Hilliard coming off that kind of usage. He’s in the RB2 discussion for PPR leagues.

The other interesting situation here is the Jets, with Carter placed on IR earlier this week. Johnson and Tevin Coleman figure to split work for the Jets in the backfield in a great matchup against the Texans, but can you actually trust either? Johnson played 20 snaps in Week 12 and had one carry and one target; Coleman rushed for a whopping 16 yards on five carries with one target of his own. Coleman probably needs a touchdown to have much Fantasy value, so you’re hoping Johnson splits carries with him and gets a decent passing game role. He’s more of an RB3, while Coleman is truly just a desperation play — it wouldn’t shock me to see La’Mical Perine out produce him. 

The Seahawks RB absences are also worth noting. Alex Collins figures to be the leading rusher against Washington, but DeeJay Dallas did match him in snaps last week, so he’s an interesting beat-the-waiver-wire add this morning just in case he pushes Collins this week. 

These two are looking like game-time decisions, which isn’t a bad thing for those of you with Patterson, who plays at 1.  If Patterson is active, you’re playing him — he’s been one of the best players in Fantasy this season and has an excellent matchup against the Jaguars on the way. If he doesn’t play, my preference would be to avoid the Atlanta backfield, but that may not be possible, so I would prefer Mike Davis to Wayne Gallman, especially in PPR. He wouldn’t be a top-24 RB, however. 

The problem with Jones is he doesn’t play until 4:25 p.m., so if you have to make a decision early, he’s putting you in a tough spot. NFL Network’s Tom Pelissero reported Sunday morning there is “optimism” around Jones, who is pushing to play and will go through pre-game warmups to prove he’s ready. The problem is, the Packers tend to be pretty conservative with injuries, and with a Week 13 bye coming up, they may opt to give him two full weeks to get back to full strength. I can’t see into the future, so I can’t tell you whether to sit an early player for Jones; if you have a viable replacement in the late slate of games, it’s worth the risk, but otherwise, I would probably pass. AJ Dillon figures to see a solid role no matter what and is a decent starter even if Jones plays, so I would probably just keep him active.

Likely in: Saquon Barkley (ankle), Kareem Hunt (calf), Elijah Mitchell (finger), Damien Harris (neck), Rhamondre Stevenson (knee) 

I’m willing to start Barkley and Hunt as top-20 running backs this week and Mitchell is right in that range as well, so you’re probably starting all three of those guys. And I’m probably passing on the Patriots duo, since both are expected to play and it’s not like we have any reason one way or the other to consider one or the other more likely to be limited — injury details don’t tend to leak out for the Patriots. Expect another timeshare there, one that makes them both fringe Fantasy options until something changes to give one of them a real advantage. You’re hoping for a touchdown either way.  

Wide receivers

  • Out: A.J. Brown (chest; IR), Corey Davis (groin), Antonio Brown (ankle), Sterling Shepard (quadriceps), Kadarius Toney (quad), Auden Tate (thigh), Anthony Schwartz (concussion), Ben Skowronek (back)
  • Legitimately questionable: Allen Lazard (shoulder), Donovan Peoples-Jones (groin), Curtis Samuel (groin), Nico Collins (hip), Adam Humphries (hip)
  • Expected to play: Marquise Brown (thigh)

The Titans already have Julio Jones and Marcus Johnson on IR, so they are incredibly short-handed for this one. Dez Fitzpatrick, Chester Rogers, and Nick Westbrook-Ikhine led the team in WR snaps last week, and Westbrook is the only one you could even consider starting coming off a 100-yard game, but you’d probably have to be pretty desperate to do so — he turned eight targets into 29 yards in Week 4 against the Jets the last time Brown was out. He’s not a top-40 WR for me. 

I’m starting Marquise Brown in his return against the Browns, and it really doesn’t take much thought. He’d been a bit disappointing prior to the injury, with fewer than 40 yards in two of his previous four games, however he also had 44 targets in those four games, so there’s no way I’m not starting him. He’s a top-15 WR, while Rashod Bateman is in the WR3 discussion as he’s had at least six targets in each of the first five games of his career. 

Tight ends

The hope is that Thomas will be activated from IR prior to Monday’s game, but given the late kickoff there, you can’t take the risk that he won’t play unless you want to add Gerald Everett as a fill in just in case. I like Thomas’ chances of returning to be a viable starting Fantasy option, however, so if he’s available in your league, I would go out and add him unless I’ve got one of the handful of no-doubt-about-it, must-start tight ends. 

Updated rankings

Here are my latest rankings as of Sunday morning: 

Quarterback

  1. Lamar Jackson vs. CLE
  2. Tom Brady @IND
  3. Jalen Hurts @NYG
  4. Justin Herbert @DEN
  5. Aaron Rodgers vs. LAR
  6. Tua Tagovailoa vs. CAR
  7. Cam Newton @MIA
  8. Matthew Stafford @GB
  9. Kirk Cousins @SF
  10. Joe Burrow vs. PIT
  11. Russell Wilson @WAS
  12. Tyrod Taylor vs. NYJ
  13. Teddy Bridgewater vs. LAC
  14. Taylor Heinicke vs. SEA
  15. Ben Roethlisberger @CIN
  16. Carson Wentz vs. TB
  17. Matt Ryan @JAX
  18. Daniel Jones vs. PHI
  19. Mac Jones vs. TEN
  20. Trevor Lawrence vs. ATL
  21. Jimmy Garoppolo vs. MIN

Running back

  1. Christian McCaffrey @MIA
  2. Jonathan Taylor vs. TB
  3. Najee Harris @CIN
  4. Austin Ekeler @DEN
  5. Dalvin Cook @SF
  6. Joe Mixon vs. PIT
  7. Cordarrelle Patterson @JAX
  8. Leonard Fournette @IND
  9. Darrell Henderson @GB
  10. Saquon Barkley vs. PHI
  11. James Robinson vs. ATL
  12. Nick Chubb @BAL
  13. Myles Gaskin vs. CAR
  14. Dontrell Hilliard @NE
  15. Antonio Gibson vs. SEA
  16. Miles Sanders @NYG
  17. Aaron Jones vs. LAR
  18. Kareem Hunt @BAL
  19. Elijah Mitchell vs. MIN
  20. AJ Dillon vs. LAR
  21. Ty Johnson @HOU
  22. Melvin Gordon vs. LAC
  23. Javonte Williams vs. LAC
  24. D’Onta Foreman @NE
  25. Alex Collins @WAS
  26. Damien Harris vs. TEN
  27. Rhamondre Stevenson vs. TEN
  28. Devonta Freeman vs. CLE
  29. David Johnson vs. NYJ
  30. Mike Davis @JAX
  31. Deejay Dallas @WAS
  32. Latavius Murray vs. CLE
  33. J.D. McKissic vs. SEA
  34. Nyheim Hines vs. TB
  35. Boston Scott @NYG
  36. Jeff Wilson vs. MIN
  37. Devontae Booker vs. PHI
  38. Alexander Mattison @SF
  39. Rex Burkhead vs. NYJ
  40. Brandon Bolden vs. TEN

Wide receivers

  1. Davante Adams vs. LAR
  2. Cooper Kupp @GB
  3. Justin Jefferson @SF
  4. Keenan Allen @DEN
  5. Deebo Samuel vs. MIN
  6. Diontae Johnson @CIN
  7. Chris Godwin @IND
  8. D.J. Moore @MIA
  9. Mike Evans @IND
  10. Ja’Marr Chase vs. PIT
  11. Marquise Brown vs. CLE
  12. Terry McLaurin vs. SEA
  13. D.K. Metcalf @WAS
  14. Tyler Lockett @WAS
  15. Brandin Cooks vs. NYJ
  16. Jaylen Waddle vs. CAR
  17. Michael Pittman vs. TB
  18. Jerry Jeudy vs. LAC
  19. Elijah Moore @HOU
  20. Adam Thielen @SF
  21. Tee Higgins vs. PIT
  22. Chase Claypool @CIN
  23. Jamison Crowder @HOU
  24. Odell Beckham  @GB
  25. DeVonta Smith @NYG
  26. Brandon Aiyuk vs. MIN
  27. Rashod Bateman vs. CLE
  28. Mike Williams @DEN
  29. Kenny Golladay vs. PHI
  30. Jarvis Landry @BAL
  31. Marvin Jones vs. ATL
  32. Jakobi Meyers vs. TEN
  33. Laviska Shenault  vs. ATL
  34. Tyler Boyd vs. PIT
  35. Courtland Sutton vs. LAC
  36. Nick Westbrook-Ikhine @NE
  37. Van Jefferson @GB
  38. T.Y. Hilton vs. TB
  39. Dez Fitzpatrick @NE
  40. Russell Gage @JAX

Tight end

  1. Mark Andrews vs. CLE
  2. George Kittle vs. MIN
  3. Rob Gronkowski @IND
  4. Kyle Pitts @JAX
  5. Mike Gesicki vs. CAR
  6. Dallas Goedert @NYG
  7. Dan Arnold vs. ATL
  8. Evan Engram vs. PHI
  9. Tyler Higbee @GB
  10. Pat Freiermuth @CIN
  11. Noah Fant vs. LAC
  12. Hunter Henry vs. TEN
  13. Jared Cook @DEN
  14. Tyler Conklin @SF
  15. Logan Thomas vs. SEA
  16. Austin Hooper @BAL
  17. O.J. Howard @IND
  18. David Njoku @BAL
  19. Gerald Everett @WAS
  20. C.J. Uzomah vs. PIT

Upright trainer review 2021 | Medical News Today

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process.

The Upright Go device is a product that a person can place on their upper back using a hypoallergenic adhesive. The company Upright created this wearable device to detect posture issues and alert a person to adjust their position when necessary. Further medical research is necessary to establish whether wearable postural devices offer positive, long-term effects.

The American Chiropractic Association says good posture can:

  • help keep the bones and joints aligned
  • reduce stress on the ligaments
  • allow muscles to work correctly
  • prevent muscle strain and pain

This article looks at how the Upright Go device works and how it may help improve a person’s posture.

Upright comes with a medical-grade, silicone adhesive patch that a person uses to attach the Upright Go to their upper back. The adhesives are hypoallergenic and reusable. Once in place, the device uses biofeedback to track an individual’s posture. If they slouch, the device will gently vibrate, prompting them to stand or sit in a more straight position.

If a person prefers not to attach the device directly to their skin, they can use the Upright Go necklace that holds the device in the correct position. The necklace comes in a choice of six colors, and the company sells them separately for around $20.

The device syncs with a compatible smartphone app that records statistics and posture progress.

There are two different Upright Go devices: the Go S, and the Go 2. Although both products are similar, the Go 2 has more features and is slightly more expensive.

They both draw power from a rechargeable lithium-polymer battery that takes approximately 3 hours to charge fully.

Both models are compatible with the same smartphone app.

Below is a table showing the differences between the two devices.

Adhesives

The hypoallergenic adhesives the device comes with are reusable and can last for up to 10 applications with correct use.

However, although the company state the adhesives are hypoallergenic, it is not clear if the brand has carried out studies regarding any skin side effects due to using the product. Therefore, a person should exercise caution and consider an appropriate allergy patch test before using the adhesives.

An adhesive removal tool that resembles a guitar pick is included with the device to aid sticker removal. It also comes with alcohol cleaning wipes.

Both models work with the Upright smartphone app, which is free to download and compatible with both iOS and Android devices.

The app offers real-time posture feedback, with an on-screen avatar mimicking the movement and body position of the wearer. The avatar turns red when a person wearing the device slouches or hunches.

Additionally, an individual can set personalized daily goals, view posture statistics, and keep track of progress. In-app support and live chats are also available.

Shipping within the United States is free, and U.S. customers will receive their order within 5–8 business days.

While Upright ships worldwide, international customers are responsible for paying any applicable customs charges.

Returns

Upright offers a 30-day money-back guarantee that starts from the date of receipt of the product.

However, to receive a refund, a person must show they followed their in-app training plan and reached their daily goal for at least 4 days.

Warranty

The company provides a 1-year limited consumer warranty, which covers manufacturer and material defects.

Upright claims that over 500 clinics worldwide recommend these devices, which have clinical validation from four published studies indicating their effectiveness.

The company uses biofeedback technology within its Upright products. A 2021 study asked participants to complete a computer task twice — once as normal, then a second time wearing a posture biofeedback device. The authors of the study concluded that individuals experienced improved posture when using the device.

However, a 2019 review of wearable postural devices stated that much more research is necessary to establish whether or not there are medical benefits.

Research suggests this type of device may benefit the following groups:

  • Office workers: The above 2021 study suggests this type of device may benefit office workers or those who spend long periods at a computer.
  • People with neck pain: A 2019 study suggests that improved posture may benefit those with neck pain in the short term. However, further research to determine its long-term effects is necessary.
  • Individuals with lower back pain: Research from 2018 found that a wearable biofeedback device may reduce lower back pain and discomfort.
  • Those with Parkinson’s disease: A 2019 study suggests the Upright Go offers postural benefits, particularly regarding neck flexibility, in people with Parkinson’s disease. However, wider research is necessary to help establish the ability of those with this condition to use the device. It also stated that long-term effects need monitoring in individuals with Parkinson’s disease who use the machines.

Additionally, a 2020 study suggests these wearable devices may improve fatigue, confidence, and overall stress ratings.

The Upright Go appears to be one of the only wearable posture devices readily available to purchase. However, several others are now no longer available.

PostureMinder

This is an app that a person can install on their computer. It provides pop-up notifications to remind individuals to sit up straight and take breaks from their screens.

A person can set the time interval when they would like these notifications to appear. In addition, an individual can also turn them on or off easily.

Posture correctors

A person may also look into purchasing a posture corrector, aid, or brace. These are products a person wears around their arms and back that pull back the shoulders, encouraging them to stand and sit up straight.

However, to avoid dependence on this kind of brace, an individual should consider only wearing them for a short time. People should also speak with a doctor or qualified healthcare professional if they have concerns about their posture or alignment.

The Upright Go device is a wearable product that a person attaches to their back using adhesives. They can also wear it with a bespoke necklace that holds it in place.

The device provides gentle vibrations when an individual slouches as a reminder to correct their posture. The compatible mobile app allows people to view their posture in real-time and monitor their progress over time.

Research suggests this device may improve posture and reduce any associated pain from slouching. However, finding the long-term effects and medical implications of these devices require further and broader research.